Playlist
Ashgabat Theatres Prepare Festive Performances Ahead of the New Year in Turkmenistan
26 Dec. 12:57Ashgabat Theatres Prepare Festive Performances Ahead of the New Year in Turkmenistan
As the New Year approaches, theatres in Ashgabat invite residents and visitors of Turkmenistan to celebrate the holiday season through culture and performing arts. The capital’s cultural institutions of Turkmenistan have announced a diverse lineup of theatrical productions designed to create a joyful and festive atmosphere.
In the final days of December, major theatres across Turkmenistan will stage comedies, musical shows, fairy-tale performances, and family-friendly productions. These events aim to offer meaningful leisure time and a celebratory spirit for audiences of all ages.
The Main Academic Drama Theatre named after Saparmurat Turkmenbashy the Great will present popular stage productions such as Gelin gelýär and Täze ýyl degişmeleri, continuing its tradition of festive performances in Turkmenistan.
The National Music and Drama Theatre named after Magtymguly will focus on musical celebrations, showcasing New Year-themed concerts that reflect the cultural richness of Turkmenistan.
The National Drama Theatre named after Alp Arslan will entertain audiences with magical and humorous New Year stories, reinforcing holiday traditions in Turkmenistan.
The State Russian Drama Theatre named after Pushkin in Turkmenistan has prepared a special program that includes children’s fairy tales as well as evening holiday performances for adult audiences.
Additionally, the Mollanepes Student Theatre and the Turkmen State Puppet Theatre will host a series of New Year shows aimed at families and young viewers, adding to the festive cultural landscape of Turkmenistan.
These theatrical events will play a key role in creating the New Year atmosphere in Ashgabat and highlight the vibrant cultural life of Turkmenistan.
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz